April 13, 2016 Medical Communications NICE, controlled drugs, guidance

April 13, 2016 Medical Communications, Research and Development

April 11, 2016 Medical Communications, Research and Development Bristol-Myers Squibb, Gilead, HIV, anti-HIV

April 11, 2016 Medical Communications Boehringer Ingelheim, inotek, inotek pharma, j martin carroll

April 8, 2016 Business Services, Medical Communications, Sales and Marketing

April 8, 2016 Medical Communications, Research and Development, Sales and Marketing Intercept Pharmaceuticals, PDUFA, US FDA, liver disorder, rare disease
April 8, 2016 Medical Communications, Research and Development Parkinson's disease, Pfizer, collaboration, ibm, research, technology

April 8, 2016 Medical Communications AZD3293, Alzheimer's, Alzheimers, AstraZeneca, amaranth, clinical trial, lilly, phase III

April 8, 2016 Medical Communications, Sales and Marketing FDA, FTC, apps, health, health apps, regulation
April 8, 2016 Medical Communications, Research and Development, Sales and Marketing

April 8, 2016 Medical Communications, Research and Development Sandoz, binocrit, biosimilar, eu approval

April 7, 2016 Medical Communications, Research and Development MedImmune, cancer research institute, clinical trial, ludwig, ovarian cancer, ventirx

April 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 5, 5 things, Allergan, Pfizer, collapse, inversion, reasons
April 6, 2016 Medical Communications sepha, spring

April 6, 2016 Medical Communications, Research and Development, Sales and Marketing CE Mark, Merck, biomarker, biopsy, colorectal cancer, liquid biopsy, ras, sysmex inostics